Preformulation Study of Aloesin in Buffered Aqueous Solutions

완충 수용액 중 Aloesin의 전처방화 연구

  • 이윤진 (동덕여자대학교 약학대학) ;
  • 곽혜선 (동덕여자대학교 약학대학) ;
  • 전인구 (동덕여자대학교 약학대학)
  • Published : 2002.06.01

Abstract

The physicochemical properties of aloesin, which has been recently found to reduce renal toxicity induced by cis-platin, were studied including solubility, partition coefficient ( $P_{c}$ ), osmolality, and stability. The solubility of aloesin was about 500 mg/mι, and the $P_{c}$ value for n-octanol/water was 1.01 $\pm$ 0.03. The degradation of aloesin followed the pseudo-first-order kinetics and was dependent on temperature, pH and ionic strength. From the pH-rate profile, the optimal pH was found to be 2.0~3.0. Some metal ions increased the degradation rate in the rank order of M $n^{2+}$ > F $e^{3+}$ > C $u^{2+}$ > F $e^{2+}$. On the other hand, other metal ions such as B $i^{3+}$, $Ba^{2+}$, Z $n^{2+}$, N $i^{2+}$, $Co^{2+}$ and $Mg^{2+}$ did not show the unfavorable effects. After autoclaving, aloesin contents remaining were 81.8~98.8% of initial concentrations depending on pH. The most stable pH was 3.98 in the autoclaving. Osmolality increased linearly as concentration increased.sed.creased.sed.

Keywords

References

  1. Jin, Y. H., Lee, S.J., Chung, M. H., Park, J. H., Park, Y. I.,Cho, T. H. and Lee, S. K. : Aloesin and arbutin inhibit tyrosinase activity in a synergistic manner via a different action mechanism. Arch. Pharm. Res. 22, 232 (1999) https://doi.org/10.1007/BF02976355
  2. 김동현, Prokidin의 랫드에서 흡수, 분포, 대사 및 배설 연구, 한국과학기술원 생체대사연구센터 (2000)
  3. Hajdu, J., Adams, G. and Lee, H. K. : Preformulation study of pelrinone hydrochloride. J. Pharm. Sci. 77, 921 (1988) https://doi.org/10.1002/jps.2600771104
  4. Parasrampuria, J. and Gupta, V. D. : Preformulation studies of acetazolamide: effect of pH, two buffer species, ionic strength, and temperature on its stability.J. Pharm. Sci. 78, 855 (1989)
  5. Pramar, Y. and Gupta, V. D.: Preformulation studies of spironolactone: effect of pH, two buffer species, ionic strength, and temperature on stability. J. Pharm. Sci. 80, 551 (1991)
  6. Freeke Hamelijnck, M. A., Stevenson, P. J., Kadaba, P. K. and Damani,L. A : Preformulationdegradation kinetics and chemical stability of a novel triazoline anticonvulsant. J. Pharm. Sci. 81, 392 (1992) https://doi.org/10.1002/jps.2600810421
  7. Longhi, M. R., de Bertorello, M. M. and Granero, G. E. : Isoxazoles. 8. Preformulation studies of an isoxazolylnaphthoquinone derivative. J. Pharm. Sci, 83, 336 (1994)
  8. Chun, I. K. and Cho, Y. M. : Influence of pH, temperature, ionic strength and metal ions on the degradation of an iridoid glucoside, aucubin, in buffered aqueous solutions. J. Kor. Pharm. Sci. 25, 239 (1995)
  9. Kostecka, D., Duncan, M. R. and Wagenknecht, D. : Formulation of a stable parenteral product; clonidine hydrochloride injection. J. Pharm. Sci. Technol, 52, 320 (1998)
  10. Gwak, H. S. and Chun, I. K.: Preformulationstudy of aspaIatone, a new antithrombotic agent. J. Appl. Pharmacol. 8, 332 (2000)
  11. Kristl, A. and Vrecer, F : Preformulation investigation of the novel proton pump inhibitor lansoprazole. Drug Dev. Ind. Pharm, 26, 781 (2000)
  12. Rivera,A B., Hernandez, R. G., Novoa de Armas H., Elizastegi, D. M. and Losada, M. V. : Physico-chemical and solid-state characterization of secnidazole. Farmaco. 55, 700 (2000) https://doi.org/10.1016/S0014-827X(00)00096-3